A Prospective Study on Online Adaptive Radiotherapy (ART) Using the ETHOS Linear Accelerator for Various Tumor Entities and the Feasibility of Integrating Multi-Parametric Patient Data Into the Adaptive Workflow

Status: Recruiting
Location: See location...
Intervention Type: Radiation
Study Type: Observational
SUMMARY

The study focuses on the scientific and clinical evaluation of online adaptive radiotherapy (ART) using the Varian/SHS ETHOS treatment system. In this study, radiation treatment plans are dynamically adjusted on a daily basis over several weeks of therapy to account for anatomical shifts in either the tumour or adjacent normal tissue - a capability that has been difficult to achieve due to technical limitations. With the ETHOS accelerator, such real-time adjustments can be made based on cone beam computed tomography (CBCT). This is a prospective observational study with the primary objective of investigating the feasibility and acceptability of performing ART with ETHOS for different tumour entities. The study will also evaluate the feasibility of integrating multi-parametric data sets into the ART workflow, such as standardised electronic feedback on treatment toxicity from both patients (ePROMS) and physicians (ePRT).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:

• Adult patients (\>18 years)

• All tumor entities with an indication for radiotherapy and/or chemoradiotherapy

• Signed informed consent

Locations
Other Locations
Germany
Charité - Universitätsmedizin
RECRUITING
Berlin
Contact Information
Primary
Goda Kalinauskaite, MD
goda.kalinauskaite@charite.de
+49 30 450 527318
Backup
Carolin Senger, MD
carolin.senger@charite.de
+49 30 450 527318
Time Frame
Start Date: 2023-10-11
Estimated Completion Date: 2027-10-09
Participants
Target number of participants: 649
Sponsors
Leads: Charite University, Berlin, Germany

This content was sourced from clinicaltrials.gov

Similar Clinical Trials